Brind.

ABVC licensed four IND-stage drug assets to OncoX BioPharma on August 1, 2025.

1 report, 1 independent Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

ABVC licensed four IND-stage drug assets to OncoX BioPharma on August 1, 2025.

Who's involved

What this event is mainly about
BioPharma

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • NewMediaWireOncoX Deepens ABVC Alliance CEO Yen Wen Pin's IPO Vision Gains Traction as OncoX Expands Pipeline SILICON VALLEY, CA - August 1, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"),